Retatrutide Minimum Order Quantity: Cost per mg by Tier

A minimum order quantity note on a retatrutide listing states the smallest order the seller will process, expressed either as a vial count or a dollar floor. It sets your minimum outlay and how much material you end up holding. It does not, by itself, change what you pay per milligram. At the vial prices this register tracked as of September 2026, 10 mg vials worked out to $10.00/mg and 20 mg vials to $9.75/mg whether the minimum was one vial or ten. An MOQ costs you only when it pushes you into a vial size or a cart total you would not otherwise have chosen.

Does a minimum order quantity change the price per mg?

Not in the two-size case this register tracks. The per-mg rate belongs to the vial, not to the order: rate = vial price ÷ vial mg. A 10 mg vial at $100 is $100 ÷ 10 = $10.00/mg. A 20 mg vial at $195 is $195 ÷ 20 = $9.75/mg. An MOQ multiplies both the numerator and the denominator, so the rate holds flat across every tier.

Minimum (vials)	Vial size (mg)	Outlay (USD)	Material (mg)	Rate (USD/mg)
1	10	100	10	10.00
2	10	200	20	10.00
5	10	500	50	10.00
10	10	1,000	100	10.00
1	20	195	20	9.75
2	20	390	40	9.75
5	20	975	100	9.75

What an MOQ multiplies and what it leaves alone. Outlay = vial price × minimum; Material = vial mg × minimum; Rate = outlay ÷ material. The two vial prices ($100 for 10 mg, $195 for 20 mg) are this register’s tracked figures as of September 2026; every other cell is arithmetic on them.

Read the two 100 mg rows against each other. Ten 10 mg vials cost $1,000 and five 20 mg vials cost $975 for identical material, a $25 gap, or 2.5% ($0.25 of $10.00). That 2.5% is the entire size penalty, and it is small enough that a seller’s MOQ on the small vial rarely matters as much as buyers assume. All quantities on this page are research-supply figures; the material is sold for research use only.

Unit minimums or dollar minimums: which is harder to clear?

A dollar floor is the one that bites, because it can force you past the quantity you wanted. Take a stated $250 order minimum against the same two sizes. Two 10 mg vials come to $200 and miss it. Three come to $300, clear it, and give you 30 mg at $10.00/mg. One 20 mg vial is $195 and misses; two are $390 for 40 mg you may not want.

The cheapest cart that clears a $250 floor is one of each size: $195 + $100 = $295 for 30 mg, which is $295 ÷ 30 = $9.83/mg. Same 30 mg as the three-small-vial route, $5 cheaper, and a rate that sits between the two vial rates because the cart is a blend of them. Sellers almost never point this out, and their cart software will not do it for you.

A unit floor is blunter but more predictable. A two-vial minimum on the 20 mg size is $390 before anything else lands on the invoice, regardless of what you needed. Check the floor against the full invoice rather than the vial line alone, since listings that fold bacteriostatic water and syringes into the order change your real outlay without touching the stated MOQ; the way bundled supply kits get priced determines how much of a dollar floor is vial and how much is consumables.

Is a two-vial minimum large or small against a real protocol?

Small. Published weekly-dosing programs in the incretin class give a workable yardstick for how fast milligrams get consumed. The VENTURE phase 2 study of VK2735, a GIP/GLP-1 dual agonist, ran 13 weeks in adults with obesity or overweight, with 140 participants on active treatment and 34 on placebo, dose arms from 2.5 mg to 15 mg weekly, and a primary endpoint of percent body-weight change at week 13; mean reduction was 9.2 kg in the 2.5 mg arm and 14.6 kg in the 15 mg arm, against 1.8 kg on placebo, per the VENTURE phase 2 dose-ranging report.

Run that schedule as arithmetic: 13 weekly administrations at the 15 mg step is 13 × 15 = 195 mg of material. That is ten 20 mg vials, $1,950 at September 2026 pricing, with 5 mg spare. A two-vial minimum is 40 mg, roughly 2.7 of those 13 weeks (40 ÷ 15 = 2.67). The figures above are a different compound’s published schedule used as a scale reference, not a retatrutide dose; per-administration retatrutide amounts are not in the sources this page draws on.

Milligram burn is not constant across the class, which is why one vial minimum means different things for different compounds. A 2025 systematic review of 19 randomized trials covering 13,529 participants compared tirzepatide at 10 or 15 mg weekly against semaglutide 2.4 mg and liraglutide 3.0 mg weekly, per the comparative safety review of GLP-1/GIP co-agonists. At 2.4 mg per administration a single 20 mg vial covers eight administrations (20 ÷ 2.4 = 8.3); at 15 mg it covers one.

Ladders also step upward over time. Tirzepatide’s approved schedule runs 5, 10 and 15 mg once weekly with titration recommended every four weeks, per a 2025 review of tirzepatide in type 2 diabetes. A buyer who clears a large MOQ at the bottom of a ladder holds most of that material through months of storage before the higher steps consume it, which turns a purchasing question into a stability question.

What does the MOQ note imply about the seller?

Three readings, in rough order of how often they hold:

1. Fulfilment cost. Cold-pack shipping and customs paperwork cost the same on a one-vial order as a ten-vial order, so a low-margin seller sets a floor to stop losing money on singles. A $250 dollar floor on a catalog whose cheapest vial is $100 is a fulfilment floor, not a demand signal.
2. Lot position. A minimum that moves from 1 vial to 5 without a price change usually tracks a new lot arriving in larger units rather than a supply squeeze. That kind of change shows up alongside the stock wording on a listing, and the two should move together; when the MOQ jumps and the availability line stays untouched, one of them is stale.
3. Break-bulk structure. A seller who buys sealed lots and splits them inherits the upstream lot minimum and passes it down. A high MOQ on one compound and a MOQ of 1 on everything else is a strong tell for that arrangement, and it is one of the cheaper ways to work out whether you are looking at a primary source or a middle layer.

What should you check before accepting a stated MOQ?

1. Whether the MOQ is per SKU or per order. A five-vial minimum spread across sizes is a different cart from five of one size.
2. Whether the dollar floor counts shipping and payment fees. A $250 floor that includes a $35 ship charge is a $215 product floor.
3. Whether a mixed-size cart clears a dollar floor cheaper, as the $295-for-30 mg case above shows.
4. Whether the per-mg rate at the forced quantity still beats the smaller vial. At a 2.5% spread, it usually does; at a wider spread, recompute.
5. The revision date on the listing, since an MOQ carried over from a prior lot is one of the fields that goes stale without being corrected.

If a seller states an MOQ in dollars, the single most useful number to derive before ordering is the cheapest mixed cart that clears it: run every combination of the listed sizes, take the lowest total at or above the floor, and divide by total milligrams. On a catalog with two vial sizes that is a handful of combinations you can work out on paper before the cart page loads.